Female ICD-10-PCS Codes

The following 2,289 ICD-10-PCS codes are intended for females as each code is clinically and virtually impossible to be applicable to a male.

Displaying codes 1,901-2,000 of 2,289:

  • 10Y04ZT Transplantation of Female Reproductive System into Products of Conception, Percutaneous Endoscopic Approach
  • 10Y04ZV Transplantation of Male Reproductive System into Products of Conception, Percutaneous Endoscopic Approach
  • 10Y04ZY Transplantation of Other Body System into Products of Conception, Percutaneous Endoscopic Approach
  • 10Y07ZE Transplantation of Nervous System into Products of Conception, Via Natural or Artificial Opening
  • 10Y07ZF Transplantation of Cardiovascular System into Products of Conception, Via Natural or Artificial Opening
  • 10Y07ZG Transplantation of Lymphatics and Hemic into Products of Conception, Via Natural or Artificial Opening
  • 10Y07ZH Transplantation of Eye into Products of Conception, Via Natural or Artificial Opening
  • 10Y07ZJ Transplantation of Ear, Nose and Sinus into Products of Conception, Via Natural or Artificial Opening
  • 10Y07ZK Transplantation of Respiratory System into Products of Conception, Via Natural or Artificial Opening
  • 10Y07ZL Transplantation of Mouth and Throat into Products of Conception, Via Natural or Artificial Opening
  • 10Y07ZM Transplantation of Gastrointestinal System into Products of Conception, Via Natural or Artificial Opening
  • 10Y07ZN Transplantation of Hepatobiliary and Pancreas into Products of Conception, Via Natural or Artificial Opening
  • 10Y07ZP Transplantation of Endocrine System into Products of Conception, Via Natural or Artificial Opening
  • 10Y07ZQ Transplantation of Skin into Products of Conception, Via Natural or Artificial Opening
  • 10Y07ZR Transplantation of Musculoskeletal System into Products of Conception, Via Natural or Artificial Opening
  • 10Y07ZS Transplantation of Urinary System into Products of Conception, Via Natural or Artificial Opening
  • 10Y07ZT Transplantation of Female Reproductive System into Products of Conception, Via Natural or Artificial Opening
  • 10Y07ZV Transplantation of Male Reproductive System into Products of Conception, Via Natural or Artificial Opening
  • 10Y07ZY Transplantation of Other Body System into Products of Conception, Via Natural or Artificial Opening
  • 2Y04X5Z Change Female Genital Tract Packing Material
  • 2Y44X5Z Packing of Female Genital Tract using Packing Material
  • 2Y54X5Z Removal of Female Genital Tract Packing Material
  • 30273H1 Transfusion of Nonautologous Whole Blood into Products of Conception, Circulatory, Percutaneous Approach
  • 30273J1 Transfusion of Nonautologous Serum Albumin into Products of Conception, Circulatory, Percutaneous Approach
  • 30273K1 Transfusion of Nonautologous Frozen Plasma into Products of Conception, Circulatory, Percutaneous Approach
  • 30273L1 Transfusion of Nonautologous Fresh Plasma into Products of Conception, Circulatory, Percutaneous Approach
  • 30273M1 Transfusion of Nonautologous Plasma Cryoprecipitate into Products of Conception, Circulatory, Percutaneous Approach
  • 30273N1 Transfusion of Nonautologous Red Blood Cells into Products of Conception, Circulatory, Percutaneous Approach
  • 30273P1 Transfusion of Nonautologous Frozen Red Cells into Products of Conception, Circulatory, Percutaneous Approach
  • 30273Q1 Transfusion of Nonautologous White Cells into Products of Conception, Circulatory, Percutaneous Approach
  • 30273R1 Transfusion of Nonautologous Platelets into Products of Conception, Circulatory, Percutaneous Approach
  • 30273S1 Transfusion of Nonautologous Globulin into Products of Conception, Circulatory, Percutaneous Approach
  • 30273T1 Transfusion of Nonautologous Fibrinogen into Products of Conception, Circulatory, Percutaneous Approach
  • 30273V1 Transfusion of Nonautologous Antihemophilic Factors into Products of Conception, Circulatory, Percutaneous Approach
  • 30273W1 Transfusion of Nonautologous Factor IX into Products of Conception, Circulatory, Percutaneous Approach
  • 30277H1 Transfusion of Nonautologous Whole Blood into Products of Conception, Circulatory, Via Natural or Artificial Opening
  • 30277J1 Transfusion of Nonautologous Serum Albumin into Products of Conception, Circulatory, Via Natural or Artificial Opening
  • 30277K1 Transfusion of Nonautologous Frozen Plasma into Products of Conception, Circulatory, Via Natural or Artificial Opening
  • 30277L1 Transfusion of Nonautologous Fresh Plasma into Products of Conception, Circulatory, Via Natural or Artificial Opening
  • 30277M1 Transfusion of Nonautologous Plasma Cryoprecipitate into Products of Conception, Circulatory, Via Natural or Artificial Opening
  • 30277N1 Transfusion of Nonautologous Red Blood Cells into Products of Conception, Circulatory, Via Natural or Artificial Opening
  • 30277P1 Transfusion of Nonautologous Frozen Red Cells into Products of Conception, Circulatory, Via Natural or Artificial Opening
  • 30277Q1 Transfusion of Nonautologous White Cells into Products of Conception, Circulatory, Via Natural or Artificial Opening
  • 30277R1 Transfusion of Nonautologous Platelets into Products of Conception, Circulatory, Via Natural or Artificial Opening
  • 30277S1 Transfusion of Nonautologous Globulin into Products of Conception, Circulatory, Via Natural or Artificial Opening
  • 30277T1 Transfusion of Nonautologous Fibrinogen into Products of Conception, Circulatory, Via Natural or Artificial Opening
  • 30277V1 Transfusion of Nonautologous Antihemophilic Factors into Products of Conception, Circulatory, Via Natural or Artificial Opening
  • 30277W1 Transfusion of Nonautologous Factor IX into Products of Conception, Circulatory, Via Natural or Artificial Opening
  • 3E0E304 Introduction of Liquid Brachytherapy Radioisotope into Products of Conception, Percutaneous Approach
  • 3E0E305 Introduction of Other Antineoplastic into Products of Conception, Percutaneous Approach
  • 3E0E30M Introduction of Monoclonal Antibody into Products of Conception, Percutaneous Approach
  • 3E0E328 Introduction of Oxazolidinones into Products of Conception, Percutaneous Approach
  • 3E0E329 Introduction of Other Anti-infective into Products of Conception, Percutaneous Approach
  • 3E0E33Z Introduction of Anti-inflammatory into Products of Conception, Percutaneous Approach
  • 3E0E36Z Introduction of Nutritional Substance into Products of Conception, Percutaneous Approach
  • 3E0E37Z Introduction of Electrolytic and Water Balance Substance into Products of Conception, Percutaneous Approach
  • 3E0E3BZ Introduction of Anesthetic Agent into Products of Conception, Percutaneous Approach
  • 3E0E3GC Introduction of Other Therapeutic Substance into Products of Conception, Percutaneous Approach
  • 3E0E3HZ Introduction of Radioactive Substance into Products of Conception, Percutaneous Approach
  • 3E0E3KZ Introduction of Other Diagnostic Substance into Products of Conception, Percutaneous Approach
  • 3E0E3NZ Introduction of Analgesics, Hypnotics, Sedatives into Products of Conception, Percutaneous Approach
  • 3E0E3SF Introduction of Other Gas into Products of Conception, Percutaneous Approach
  • 3E0E3TZ Introduction of Destructive Agent into Products of Conception, Percutaneous Approach
  • 3E0E4GC Introduction of Other Therapeutic Substance into Products of Conception, Percutaneous Endoscopic Approach
  • 3E0E704 Introduction of Liquid Brachytherapy Radioisotope into Products of Conception, Via Natural or Artificial Opening
  • 3E0E705 Introduction of Other Antineoplastic into Products of Conception, Via Natural or Artificial Opening
  • 3E0E70M Introduction of Monoclonal Antibody into Products of Conception, Via Natural or Artificial Opening
  • 3E0E728 Introduction of Oxazolidinones into Products of Conception, Via Natural or Artificial Opening
  • 3E0E729 Introduction of Other Anti-infective into Products of Conception, Via Natural or Artificial Opening
  • 3E0E73Z Introduction of Anti-inflammatory into Products of Conception, Via Natural or Artificial Opening
  • 3E0E76Z Introduction of Nutritional Substance into Products of Conception, Via Natural or Artificial Opening
  • 3E0E77Z Introduction of Electrolytic and Water Balance Substance into Products of Conception, Via Natural or Artificial Opening
  • 3E0E7BZ Introduction of Anesthetic Agent into Products of Conception, Via Natural or Artificial Opening
  • 3E0E7GC Introduction of Other Therapeutic Substance into Products of Conception, Via Natural or Artificial Opening
  • 3E0E7HZ Introduction of Radioactive Substance into Products of Conception, Via Natural or Artificial Opening
  • 3E0E7KZ Introduction of Other Diagnostic Substance into Products of Conception, Via Natural or Artificial Opening
  • 3E0E7NZ Introduction of Analgesics, Hypnotics, Sedatives into Products of Conception, Via Natural or Artificial Opening
  • 3E0E7SF Introduction of Other Gas into Products of Conception, Via Natural or Artificial Opening
  • 3E0E7TZ Introduction of Destructive Agent into Products of Conception, Via Natural or Artificial Opening
  • 3E0E804 Introduction of Liquid Brachytherapy Radioisotope into Products of Conception, Via Natural or Artificial Opening Endoscopic
  • 3E0E805 Introduction of Other Antineoplastic into Products of Conception, Via Natural or Artificial Opening Endoscopic
  • 3E0E80M Introduction of Monoclonal Antibody into Products of Conception, Via Natural or Artificial Opening Endoscopic
  • 3E0E828 Introduction of Oxazolidinones into Products of Conception, Via Natural or Artificial Opening Endoscopic
  • 3E0E829 Introduction of Other Anti-infective into Products of Conception, Via Natural or Artificial Opening Endoscopic
  • 3E0E83Z Introduction of Anti-inflammatory into Products of Conception, Via Natural or Artificial Opening Endoscopic
  • 3E0E86Z Introduction of Nutritional Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic
  • 3E0E87Z Introduction of Electrolytic and Water Balance Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic
  • 3E0E8BZ Introduction of Anesthetic Agent into Products of Conception, Via Natural or Artificial Opening Endoscopic
  • 3E0E8GC Introduction of Other Therapeutic Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic
  • 3E0E8HZ Introduction of Radioactive Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic
  • 3E0E8KZ Introduction of Other Diagnostic Substance into Products of Conception, Via Natural or Artificial Opening Endoscopic
  • 3E0E8NZ Introduction of Analgesics, Hypnotics, Sedatives into Products of Conception, Via Natural or Artificial Opening Endoscopic
  • 3E0E8SF Introduction of Other Gas into Products of Conception, Via Natural or Artificial Opening Endoscopic
  • 3E0E8TZ Introduction of Destructive Agent into Products of Conception, Via Natural or Artificial Opening Endoscopic
  • 3E0P05Z Introduction of Adhesion Barrier into Female Reproductive, Open Approach
  • 3E0P304 Introduction of Liquid Brachytherapy Radioisotope into Female Reproductive, Percutaneous Approach
  • 3E0P305 Introduction of Other Antineoplastic into Female Reproductive, Percutaneous Approach
  • 3E0P30M Introduction of Monoclonal Antibody into Female Reproductive, Percutaneous Approach
  • 3E0P328 Introduction of Oxazolidinones into Female Reproductive, Percutaneous Approach
  • 3E0P329 Introduction of Other Anti-infective into Female Reproductive, Percutaneous Approach